Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy

The antihyerlipidemic drug atorvastatin (ATR) is used worldwide as part of the strategy to prevent cardiovascular events. The high prevalence of patient nonadherence remains an important challenge which could be addressed efficiently by precision pharmacotherapy based on therapeutic drug monitoring...

Full description

Bibliographic Details
Main Authors: Gellért Balázs Karvaly, István Vincze, István Karádi, Barna Vásárhelyi, András Zsáry
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/5/1324
_version_ 1827604485689573376
author Gellért Balázs Karvaly
István Vincze
István Karádi
Barna Vásárhelyi
András Zsáry
author_facet Gellért Balázs Karvaly
István Vincze
István Karádi
Barna Vásárhelyi
András Zsáry
author_sort Gellért Balázs Karvaly
collection DOAJ
description The antihyerlipidemic drug atorvastatin (ATR) is used worldwide as part of the strategy to prevent cardiovascular events. The high prevalence of patient nonadherence remains an important challenge which could be addressed efficiently by precision pharmacotherapy based on therapeutic drug monitoring (TDM). ATR is metabolized to pharmacologically active metabolites, and evidence shows that the sums of ATR acid and lactone form concentrations (ATR + ATRL), or of ATR and hydroxylated metabolites (ATR + MET) should be assayed. A method is presented for the analysis of these substances in serum. Method validation included the estimation of the quantitative relationship between the concentrations and the standard deviations (SD), which supports the optimal incorporation of TDM results into nonparametric pharmacokinetic models. The concentrations of the analytes were evaluated in human subjects receiving ATR. The method’s performance improved by taking the sums of acid and lactone concentrations into account. The concentration–SD relationship was linear, and we recommend applying Theil’s regression for estimating the assay error. All analytes could be detected by 2 h post dose in the samples of human subjects. The changes in metabolite/parent drug concentration ratios in time depended on the dose. The method is suitable for the TDM of ATR with a focus on precision pharmacotherapy.
first_indexed 2024-03-09T06:00:42Z
format Article
id doaj.art-e7296b31d34a4700938496ca7e86112c
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T06:00:42Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-e7296b31d34a4700938496ca7e86112c2023-12-03T12:09:26ZengMDPI AGMolecules1420-30492021-03-01265132410.3390/molecules26051324Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision PharmacotherapyGellért Balázs Karvaly0István Vincze1István Karádi2Barna Vásárhelyi3András Zsáry4Department of Laboratory Medicine, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, HungaryDepartment of Laboratory Medicine, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, HungaryDepartment of Internal Medicine and Hematology, Semmelweis University, Szentkirályi út 46, H-1088 Budapest, HungaryDepartment of Laboratory Medicine, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, HungaryDepartment of Internal Medicine and Hematology, Semmelweis University, Szentkirályi út 46, H-1088 Budapest, HungaryThe antihyerlipidemic drug atorvastatin (ATR) is used worldwide as part of the strategy to prevent cardiovascular events. The high prevalence of patient nonadherence remains an important challenge which could be addressed efficiently by precision pharmacotherapy based on therapeutic drug monitoring (TDM). ATR is metabolized to pharmacologically active metabolites, and evidence shows that the sums of ATR acid and lactone form concentrations (ATR + ATRL), or of ATR and hydroxylated metabolites (ATR + MET) should be assayed. A method is presented for the analysis of these substances in serum. Method validation included the estimation of the quantitative relationship between the concentrations and the standard deviations (SD), which supports the optimal incorporation of TDM results into nonparametric pharmacokinetic models. The concentrations of the analytes were evaluated in human subjects receiving ATR. The method’s performance improved by taking the sums of acid and lactone concentrations into account. The concentration–SD relationship was linear, and we recommend applying Theil’s regression for estimating the assay error. All analytes could be detected by 2 h post dose in the samples of human subjects. The changes in metabolite/parent drug concentration ratios in time depended on the dose. The method is suitable for the TDM of ATR with a focus on precision pharmacotherapy.https://www.mdpi.com/1420-3049/26/5/1324atorvastatinhydroxyatorvastatinatorvastatin lactonetherapeutic drug monitoringpharmacokineticsindividualized drug therapy
spellingShingle Gellért Balázs Karvaly
István Vincze
István Karádi
Barna Vásárhelyi
András Zsáry
Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy
Molecules
atorvastatin
hydroxyatorvastatin
atorvastatin lactone
therapeutic drug monitoring
pharmacokinetics
individualized drug therapy
title Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy
title_full Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy
title_fullStr Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy
title_full_unstemmed Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy
title_short Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy
title_sort sensitive high throughput liquid chromatography tandem mass spectrometry analysis of atorvastatin and its pharmacologically active metabolites in serum for supporting precision pharmacotherapy
topic atorvastatin
hydroxyatorvastatin
atorvastatin lactone
therapeutic drug monitoring
pharmacokinetics
individualized drug therapy
url https://www.mdpi.com/1420-3049/26/5/1324
work_keys_str_mv AT gellertbalazskarvaly sensitivehighthroughputliquidchromatographytandemmassspectrometryanalysisofatorvastatinanditspharmacologicallyactivemetabolitesinserumforsupportingprecisionpharmacotherapy
AT istvanvincze sensitivehighthroughputliquidchromatographytandemmassspectrometryanalysisofatorvastatinanditspharmacologicallyactivemetabolitesinserumforsupportingprecisionpharmacotherapy
AT istvankaradi sensitivehighthroughputliquidchromatographytandemmassspectrometryanalysisofatorvastatinanditspharmacologicallyactivemetabolitesinserumforsupportingprecisionpharmacotherapy
AT barnavasarhelyi sensitivehighthroughputliquidchromatographytandemmassspectrometryanalysisofatorvastatinanditspharmacologicallyactivemetabolitesinserumforsupportingprecisionpharmacotherapy
AT andraszsary sensitivehighthroughputliquidchromatographytandemmassspectrometryanalysisofatorvastatinanditspharmacologicallyactivemetabolitesinserumforsupportingprecisionpharmacotherapy